Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline for biochemical and anthropometric parameters in prediabetes
IRCT20170608034390N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cabergoline in prediabetes and impaired fasting glucose (IFG), sponsored by Shahid Beheshti University of Medical Sciences. Started Jun 2016; status: completed.
02
Drugs
cabergoline
03
Conditions
prediabetesimpaired fasting glucose (IFG)
Beyond the preview
Go deeper on IRCT20170608034390N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170608034390N6.